Adjuvant endocrine therapy used to treat ER+ HER2- breast cancer
Adjuvant endocrine therapy used to treat ER+ HER2- breast cancer
N-803-BCG combination shows promising results in BCG-unresponsive NMIBC
Diagnostic performance and survival outcome of SLNB procedure in breast cancer patients from a tertiary cancer care centre
War in Ukraine: Impacts on the Slovakian cancer care system
Inspiration Family: Challenges of the Ukrainian cancer charity on the frontline
War in Ukraine: Impacts on the Ukrainian cancer care system
War in Ukraine: Impacts on the Polish cancer care system and vaccination challenges
War in Ukraine: Current and future impacts on the Romanian cancer care system
Lymphoma Coalition: Challenges for Ukrainian haematological cancer patients
Recurrent non-invasive breast tumours may not always be related to the primary lesion
Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid tumours
The adverse events atlas, towards a strategy to predict synergistic adverse events of combination therapies